Cite Filings / AKTS
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)

CIK 0002035832

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Aktis Oncology, Inc.

Sign in to watch
Ticker
AKTS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
852584233
Phone
+1 978-237-4380
Business address
17 DRYDOCK AVENUE, SUITE #17-401, BOSTON, MA, 02210
Filings Financials Insiders Search text
All 72 Financials 10 Executive Compensation 7 Insider Trading 31 Beneficial Ownership Interest 6 Business Combinations 6 Public Offerings 8 Others 17
›
Filed in
  1. No filings match these filters. Clear filters
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-11-16
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-05-14
  4. SCHEDULE 13D Stake ● Beneficial Ownership Report 2026-01-20
  5. SCHEDULE 13D Stake ● Beneficial Ownership Report 2026-01-20
  6. SCHEDULE 13D Stake ● Beneficial Ownership Report 2026-01-15
  7. SCHEDULE 13D Stake ● Beneficial Ownership Report 2026-01-14

Page 1 of 1 · 6 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…